Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9524]

Economics of treating patients

Dr Richard Schilsky – University of Chicago, USA

Economics of treating patients ( Dr Richard Schilsky – University of Chicago, USA )

Heterogeneity of global cancer outcomes

Prof Reinhard Busse – Technische Universitat, Berlin, Germany

Heterogeneity of global cancer outcomes ( Prof Reinhard Busse – Technische Universitat, Berlin, Germany )

Use of bio-banks in the EurocanPlatform

Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands

Use of bio-banks in the EurocanPlatform ( Prof Peter Riegman – Erasmus Medical Centre, Rotterdam, Netherlands )

Progress of the EurocanPlatform, one year on

Prof Julio Celis – Danish Cancer Center, Copenhagen, Denmark

Progress of the EurocanPlatform, one year on ( Prof Julio Celis – Danish Cancer Center, Copenhagen, Denmark )

Update on the FP7 TRANSCAN Project

Dr Maria Ferrantini – Istituto Superiore di Sanita, Rome, Italy

Update on the FP7 TRANSCAN Project ( Dr Maria Ferrantini – Istituto Superiore di Sanita, Rome, Italy )

New approaches to personalised medicine

Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany

New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )

Bringing together the resources of Eastern and Western European institutes

Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca...

Bringing together the resources of Eastern and Western European institutes ( Prof Ioana Neagoe – Institute of Oncology ‘Prof Dr Ion Chiricuta’, Cluj-Napoca, Romania )

Goals of the German Consortium for Translational Cancer Research

Dr Hubert Serve – University of Frankfurt, Germany

Goals of the German Consortium for Translational Cancer Research ( Dr Hubert Serve – University of Frankfurt, Germany )

Recent developments in neoadjuvant therapy

Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany

Recent developments in neoadjuvant therapy ( Prof Gunter Von Minckwitz – German Breast Group, Neu-Isenburg, Germany )

Highlights and goals of IMPAKT 2012

Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium

Highlights and goals of IMPAKT 2012 ( Prof Martine Piccart – Jules Bordet Institute, Brussels, Belgium )

PI3K and the heterogeneity of small tumour breast cancer

Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium

PI3K and the heterogeneity of small tumour breast cancer ( Dr Sherene Loi – Jules Bordet Institute, Brussels, Belgium )

Molecularly characterising triple negative breast cancer

Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium

Molecularly characterising triple negative breast cancer ( Prof Jorge Reis-Filho – Jules Bordet Institute, Brussels, Belgium )

More from ecancer